Search Results - "Øy, Geir F"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma by Fiorito, Elisa, Szybowska, Patrycja, Haugsten, Ellen M., Kostas, Michal, Øy, Geir F., Wiedlocha, Antoni, Singh, Sachin, Nakken, Sigve, Mælandsmo, Gunhild M., Fletcher, Jonathan A., Meza-Zepeda, Leonardo A., Wesche, Jørgen

    Published in British journal of cancer (23-11-2022)
    “…Background Rhabdomyosarcoma (RMS) is a paediatric cancer driven either by fusion proteins (e.g., PAX3-FOXO1) or by mutations in key signalling molecules (e.g.,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma by Alver, Tine N, Lavelle, Timothy J, Longva, Ane S, Øy, Geir F, Hovig, Eivind, Bøe, Sigurd L

    Published in Oncotarget (23-08-2016)
    “…The phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway is frequently hyper-activated upon vemurafenib treatment of melanoma. We have here…”
    Get full text
    Journal Article
  4. 4

    Abstract 1049A: Deregulation of MITF in the context of inactive MC1R leads to melanocyte transformation by Alver, Tine Norman, Lavelle, Timothy J., Heintz, Karen-Marie, Wernhoff, Patrik, Nygaard, Vegard, Øy, Geir F., Bøe, Sigurd L., Urbanucci, Alfonso, Hovig, Eivind J.

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract MC1R, the cAMP pathway and the response to solar UV are all elements involved in the growth, differentiation and survival of melanocytes and in…”
    Get full text
    Journal Article